home / stock / seel / seel articles

SEEL Articles, Seelos Therapeutics Inc.

Stock Information
Company Name: Seelos Therapeutics Inc.
Stock Symbol: SEEL
Market: NYSE
Website: seelostherapeutics.com
Menu
SEEL SEEL Quote SEEL Short SEEL News SEEL Articles SEEL Message Board
Get SEEL Alerts

News, Short Squeeze, Breakout and More Instantly...
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) fell sharply during Wednesday's session after the company entered into a $10 millio...
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of VivoPower International PLC (NASDAQ:VVPR) rose sharply in today's pre-market trading after the company announced it secured an exten...

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its str...

Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results | Benzinga

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow traded up 0.63% to 3...
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS...

Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results | Benzinga

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.54% to 39,001.22 w...

Nasdaq Down 100 Points; US Housing Starts Surge In February | Benzinga

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Do...
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why | Benzinga

Tuesday, Seelos Therapeutics Inc (NASDAQ:SEEL) provided an update on top-line data of the Phase 2/3 HEALEY ALS Platform trial. ...

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More | Benzinga

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...

Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More | Benzinga

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a first-in-class clinical trial on ibogaine-magnesium th...
Next 10